NasdaqCM - Nasdaq Real Time Price USD
Immatics N.V. (IMTX)
4.6050
+0.0950
+(2.11%)
As of 1:29:30 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-158,030
-158,030
18,228
100,131
-84,746
Investing Cash Flow
-152,387
-152,387
-31,388
-209,791
7,493
Financing Cash Flow
319,684
319,684
84,516
123,710
-2,613
End Cash Position
236,748
236,748
218,472
148,519
132,994
Capital Expenditure
-16,480
-16,480
-30,957
-6,215
-5,657
Issuance of Capital Stock
343,010
343,010
90,404
134,484
94
Repayment of Debt
-2,012
-2,012
-3,849
-2,843
-2,707
Free Cash Flow
-174,510
-174,510
-12,729
93,916
-90,403
12/31/2021 - 12/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCYC Bicycle Therapeutics plc
8.29
-4.44%
MRUS Merus N.V.
43.25
+3.38%
CGEM Cullinan Therapeutics, Inc.
8.11
-3.22%
BCAX Bicara Therapeutics Inc.
15.36
-1.00%
ACLX Arcellx, Inc.
62.50
-1.78%
TYRA Tyra Biosciences, Inc.
9.93
-0.90%
EWTX Edgewise Therapeutics, Inc.
15.01
+1.21%
NAMS NewAmsterdam Pharma Company N.V.
17.23
-0.23%
NRIX Nurix Therapeutics, Inc.
11.44
-1.46%
WVE Wave Life Sciences Ltd.
6.64
-2.21%